Rebbeck, Timothy R.
Dana-Farber Cancer Institute,
United States
2025 Rank: 7861
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 217 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7861 | 7784 |
| Total Cites | 2531 | 2842 |
| H-index | 22 | 24 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 71 | 72 |
| Number of Single+First Authored Papers | 85 | 85 |
| Total Cites to Single+First Authored Papers | 319 | 339 |
| Number of Single+First+Last Authored Papers | 205 | 205 |
| Total Cites to Single+First+Last Authored Papers | 704 | 767 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2170 | 2346 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.21 |
| Self-Citation Percentage |
10.94%
|
|
Rebbeck, Timothy R.
Dana-Farber Cancer Institute,
United States
2024 Rank: 7959
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 252 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7959 | 7967 |
| Total Cites | 2126 | 2395 |
| H-index | 22 | 23 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 26 | 26 |
| Total Cites to Single Authored Papers | 77 | 77 |
| Number of Single+First Authored Papers | 85 | 85 |
| Total Cites to Single+First Authored Papers | 283 | 302 |
| Number of Single+First+Last Authored Papers | 202 | 202 |
| Total Cites to Single+First+Last Authored Papers | 631 | 688 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1773 | 1943 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
11.23%
|
|
Rebbeck, Timothy R.
Harvard T.H. Chan School of Public Health,
United States
2023 Rank: 14456
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 531 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14456 | 14705 |
| Total Cites | 1398 | 1548 |
| H-index | 20 | 20 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 23 | 23 |
| Total Cites to Single Authored Papers | 58 | 58 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 271 | 292 |
| Number of Single+First+Last Authored Papers | 161 | 161 |
| Total Cites to Single+First+Last Authored Papers | 519 | 557 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1144 | 1230 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
9.69%
|
|
Rebbeck, Timothy R.
Harvard T.H. Chan School of Public Health,
United States
2022 Rank: 13981
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 519 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13981 | 13837 |
| Total Cites | 1495 | 1709 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 23 | 23 |
| Total Cites to Single Authored Papers | 54 | 54 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 258 | 270 |
| Number of Single+First+Last Authored Papers | 159 | 159 |
| Total Cites to Single+First+Last Authored Papers | 536 | 574 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1222 | 1328 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.29 |
| Self-Citation Percentage |
12.52%
|
|
Rebbeck, Timothy R.
Harvard T.H. Chan School of Public Health,
United States
2021 Rank: 10873
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 398 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10873 | 9647 |
| Total Cites | 2488 | 2878 |
| H-index | 22 | 25 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 25 | 25 |
| Total Cites to Single Authored Papers | 105 | 107 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 445 | 477 |
| Number of Single+First+Last Authored Papers | 168 | 168 |
| Total Cites to Single+First+Last Authored Papers | 871 | 970 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1976 | 2176 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.32 |
| Self-Citation Percentage |
13.55%
|
|
Rebbeck, Timothy R.
Harvard T.H. Chan School of Public Health,
United States
2020 Rank: 11805
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 426 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11805 | 11184 |
| Total Cites | 2125 | 2490 |
| H-index | 22 | 24 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 24 | 24 |
| Total Cites to Single Authored Papers | 45 | 47 |
| Number of Single+First Authored Papers | 81 | 81 |
| Total Cites to Single+First Authored Papers | 344 | 396 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 673 | 762 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1698 | 1891 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.32 |
| Self-Citation Percentage |
14.66%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.